{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:11:06Z","timestamp":1794978666894,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"GSK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although the psychometric properties of patient-reported outcome measures (e.g. the 22-item Sino-nasal Outcomes Test [SNOT-22]) in chronic rhinosinusitis with nasal polyps (CRSwNP) have been defined, these definitions have not been extensively studied in patients with very severe CRSwNP, as defined by recurrent disease despite\u2009\u2265\u20091 previous surgery and a current need for further surgery. Therefore, the psychometric properties of the symptoms visual analogue scales (VAS) were evaluated, and meaningful within-patient change thresholds were calculated for VAS and SNOT-22.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>SYNAPSE (NCT03085797), a randomized, double-blind, placebo-controlled, 52-week trial, assessed the efficacy and safety of 4-weekly mepolizumab 100\u00a0mg subcutaneously added to standard of care in very severe CRSwNP. Enrolled patients (n\u2009=\u2009407) completed symptom VAS (six items) daily and SNOT-22 every 4\u00a0weeks from baseline until Week 52. Blinded psychometric assessment of individual and composite VAS was performed post hoc, including anchor-based thresholds for meaningful within-patient changes for VAS and SNOT-22, supported by cumulative distribution function and probability density function plots. The effect of mepolizumab versus placebo for 52\u00a0weeks on VAS and SNOT-22 scores was then determined using these thresholds using unblinded data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Internal consistency was acceptable for VAS and SNOT-22 scores (Cronbach\u2019s \u03b1-coefficients\u2009\u2265\u20090.70). Test\u2013retest reliability was demonstrated for all symptom VAS (Intra-Class Correlation coefficients\u2009&gt;\u20090.75). Construct validity was acceptable between individual and composite VAS and SNOT-22 total score (r\u2009=\u20090.461\u20130.598) and between individual symptom VAS and corresponding SNOT-22 items (r\u2009=\u20090.560\u20130.780), based upon pre-specified ranges. Known-groups validity assessment demonstrated generally acceptable validity based on factors associated with respiratory health, with all VAS responsive to change. Mepolizumab treatment was associated with significantly increased odds of meeting or exceeding meaningful within-patient change thresholds, derived for this very severe cohort using six anchor groups for individual VAS (odds ratio [OR] 2.19\u20132.68) at Weeks 49\u201352, and SNOT-22 (OR 1.61\u20132.96) throughout the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Symptoms VAS and SNOT-22 had acceptable psychometric properties for use in very severe CRSwNP. Mepolizumab provided meaningful within-patient improvements in symptom severity and health-related quality of life versus placebo, indicating mepolizumab provides substantial clinical benefits in very severe CRSwNP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41687-023-00543-5","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:16:26Z","timestamp":1674260186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study"],"prefix":"10.1186","volume":"7","author":[{"given":"Wytske","family":"Fokkens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Trigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella E.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Diamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhabita","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana R.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Yancey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Tabberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SYNAPSE study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ledit","family":"Ardusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Bergna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"De Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"El\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Maspero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Saez","family":"Scherbovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Tolcachier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Wehbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anah\u00ed","family":"Ya\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chady","family":"Sader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Del Carpio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-No\u00eblle","family":"Corriveau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Desrosiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Janjua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Kilty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Sowerby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Spafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Betz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Beule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Chaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Groeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludger","family":"Klimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Olze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wagenmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Wollenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury","family":"Yarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Ju","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun-Jong","family":"Dhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seontae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae-Seo","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Whan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Yeol","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wytske J.","family":"Fokkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriu","family":"Bronescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Mella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Neagos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doinel","family":"Radeanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalin","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Edin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Karpischenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimat","family":"Khanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Mirzabekyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Ovchinnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Polyakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Ryazantsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriy","family":"Svistushkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Tarasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Yakusevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Ahlstr\u00f6m","family":"Emanuelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Hellgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Jangard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"M\u00e5rtensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Toll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Carrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Scaddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Blotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Courville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia","family":"Damask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"DeConde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Dale","family":"Ehmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Fatakia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kerwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"LaForce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Marple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Matz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"McDuffie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayla","family":"Mumneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Ow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Rosenbloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Schlosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Shah-Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Shealy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Silvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weily","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Talreja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Tarpay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. James","family":"Wedner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"issue":"Suppl 29","key":"543_CR1","first-page":"1","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(Suppl 29):1\u2013464","journal-title":"Rhinology"},{"key":"543_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-pathol-052016-100401","volume":"12","author":"RP Schleimer","year":"2017","unstructured":"Schleimer RP (2017) Immunopathogenesis of chronic rhinosinusitis and nasal polyposis. Annu Rev Pathol 12:331\u2013357","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"543_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jaip.2016.04.012","volume":"4","author":"WW Stevens","year":"2016","unstructured":"Stevens WW, Schleimer RP, Kern RC (2016) Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract 4(4):565\u2013572","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6 Pt 1","key":"543_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","volume":"99","author":"C Bachert","year":"1997","unstructured":"Bachert C, Wagenmann M, Hauser U, Rudack C (1997) IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 99(6 Pt 1):837\u2013842","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"543_CR5","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jaci.2010.07.007","volume":"126","author":"C Bachert","year":"2010","unstructured":"Bachert C, Zhang N, Holtappels G, De Lobel L, van Cauwenberge P, Liu S et al (2010) Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol 126(5):962\u2013968","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"543_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4193\/Rhino10.295","volume":"49","author":"I Alobid","year":"2011","unstructured":"Alobid I, Cardelus S, Ben\u00edtez P, Guilemany JM, Roca-Ferrer J, Picado C et al (2011) Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis. Rhinology 49(5):519\u2013524","journal-title":"Rhinology"},{"issue":"3","key":"543_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/lary.26391","volume":"127","author":"AS DeConde","year":"2017","unstructured":"DeConde AS, Mace JC, Levy JM, Rudmik L, Alt JA, Smith TL (2017) Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope 127(3):550\u2013555","journal-title":"Laryngoscope"},{"key":"543_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13601-019-0303-6","volume":"10","author":"V Hox","year":"2020","unstructured":"Hox V, Lourijsen E, Jordens A, Aasbjerg K, Agache I, Alobid I et al (2020) Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy 10:1","journal-title":"Clin Transl Allergy"},{"key":"543_CR9","unstructured":"GSK. Nucala (mepolizumab) Highlights of prescribing information https:\/\/gskpro.com\/content\/dam\/global\/hcpportal\/en_US\/Prescribing_Information\/Nucala\/pdf\/NUCALA-PI-PIL-IFU-COMBINED.PDF. Accessed Aug 2021"},{"key":"543_CR10","unstructured":"EMA. Nucala (mepolizumab) Summary of product characteristics. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/nucala-epar-product-information_en.pdf. Accessed Nov 2021"},{"key":"543_CR11","unstructured":"GSK. European Commission approves Nucala (mepolizumab) in three additional eosinophil-driven diseases. https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/european-commission-approves-nucala-mepolizumab-in-three-additional-eosinophil-driven-diseases\/. Accessed Nov 2021"},{"issue":"4","key":"543_CR12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","volume":"140","author":"C Bachert","year":"2017","unstructured":"Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S et al (2017) Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial. J Allergy Clin Immunol 140(4):1024\u201331.e14","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"543_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","volume":"128","author":"P Gevaert","year":"2011","unstructured":"Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F et al (2011) Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 128(5):989\u2013995","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"543_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","volume":"9","author":"JK Han","year":"2021","unstructured":"Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE et al (2021) Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med 9(10):1141\u20131153","journal-title":"Lancet Respir Med"},{"issue":"1","key":"543_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4193\/Rhin17.255","volume":"57","author":"A Khan","year":"2019","unstructured":"Khan A, Vandeplas G, Huynh TMT, Joish VN, Mannent L, Tomassen P et al (2019) The global allergy and asthma European network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology 57(1):32\u201342","journal-title":"Rhinology"},{"issue":"2","key":"543_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.21053\/ceo.2015.01053","volume":"9","author":"DH Kim","year":"2016","unstructured":"Kim DH, Han K, Kim SW (2016) Effect of chronic rhinosinusitis with or without nasal polyp on quality of life in South Korea: 5th Korea national health and nutrition examination survey Korean. Clin Exp Otorhinolaryngol 9(2):150\u2013156","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"543_CR17","doi-asserted-by":"publisher","first-page":"S360","DOI":"10.1016\/j.jval.2019.04.1763","volume":"22","author":"R Hall","year":"2019","unstructured":"Hall R, Trennery C, Bradley H, Gater A, Sikirica M, Nelsen L et al (2019) PRS59 qualitative assessment of the content validity of the SNOT-22 in patients with nasal polyps. Value Health 22:S360","journal-title":"Value Health"},{"issue":"2","key":"543_CR18","doi-asserted-by":"publisher","first-page":"AB126","DOI":"10.1016\/j.jaci.2020.12.462","volume":"147","author":"M Tabberer","year":"2021","unstructured":"Tabberer M, Trigg A, Busse W, Lund V, Lee J, Bachert C et al (2021) Mepolizumab reduces disease symptoms for patients with chronic rhinosinusitis with nasal polyps: data from the SYNAPSE study. J Allergy Clin Immunol 147(2):AB126","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"543_CR19","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/alr.22028","volume":"7","author":"NI Chowdhury","year":"2017","unstructured":"Chowdhury NI, Mace JC, Bodner TE, Alt JA, Deconde AS, Levy JM et al (2017) Investigating the minimal clinically important difference for SNOT-22 symptom domains in surgically managed chronic rhinosinusitis. Int Forum Allergy Rhinol 7(12):1149\u20131155","journal-title":"Int Forum Allergy Rhinol"},{"issue":"5","key":"543_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","volume":"34","author":"C Hopkins","year":"2009","unstructured":"Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP (2009) Psychometric validity of the 22-item sinonasal outcome test. Clin Otolaryngol: Off J ENT-UK, Off J Neth Soc Oto-Rhino-Laryngol Cervico-Fac Surg 34(5):447\u201354","journal-title":"Clin Otolaryngol: Off J ENT-UK, Off J Neth Soc Oto-Rhino-Laryngol Cervico-Fac Surg"},{"issue":"5","key":"543_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jval.2019.11.005","volume":"23","author":"R Hall","year":"2020","unstructured":"Hall R, Trennery C, Chan R, Gater A, Bradley H, Sikirica MV et al (2020) Understanding the patient experience of severe, recurrent, bilateral nasal polyps: a qualitative interview study in the United States and Germany. Value Health: J Int Soc Pharmacoecon Outcomes Res 23(5):632\u2013641","journal-title":"Value Health: J Int Soc Pharmacoecon Outcomes Res"},{"issue":"4","key":"543_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.rmed.2005.08.012","volume":"100","author":"EF Juniper","year":"2006","unstructured":"Juniper EF, Bousquet J, Abetz L, Bateman ED, Committee G (2006) Identifying \u201cwell-controlled\u201d and \u201cnot well-controlled\u201d asthma using the Asthma Control Questionnaire. Respir Med 100(4):616\u2013621","journal-title":"Respir Med"},{"issue":"1","key":"543_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34\u201342","journal-title":"J Clin Epidemiol"},{"key":"543_CR24","unstructured":"Kline R (2015) Principles and practice of structural equation modeling. Fourth Edition ed: Guilford Publications"},{"issue":"2","key":"543_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/j.2333-8504.1967.tb00991.x","volume":"1967","author":"KG J\u00f6reskog","year":"1967","unstructured":"J\u00f6reskog KG (1967) A General approach to confirmatory maximum likelihood factor analysis. ETS Res Bull Ser 1967(2):183\u2013202","journal-title":"ETS Res Bull Ser"},{"key":"543_CR26","unstructured":"Brown T (2015) Confirmatory factor analysis for applied research. Second Edition ed: Guilford Publications"},{"issue":"1","key":"543_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"Hu Lt","year":"1999","unstructured":"Lt Hu, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Eq Model: Multidiscip J 6(1):1\u201355","journal-title":"Struct Eq Model: Multidiscip J"},{"issue":"4","key":"543_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/BF02296192","volume":"66","author":"A Satorra","year":"2001","unstructured":"Satorra A, Bentler PM (2001) A scaled difference chi-square test statistic for moment structure analysis. Psychometrika 66(4):507\u2013514","journal-title":"Psychometrika"},{"key":"543_CR29","unstructured":"Nunnally J. (2010) Psychometric theory. Third Edition ed: Tata McGraw-Hill Education"},{"issue":"2","key":"543_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15(2):155\u2013163","journal-title":"J Chiropr Med"},{"issue":"2 Pt 1","key":"543_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1288\/00005537-198402000-00004","volume":"94","author":"RL Doty","year":"1984","unstructured":"Doty RL, Shaman P, Kimmelman CP, Dann MS (1984) University of Pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 94(2 Pt 1):176\u2013178","journal-title":"Laryngoscope"},{"issue":"4","key":"543_CR32","first-page":"183","volume":"31","author":"VJ Lund","year":"1993","unstructured":"Lund VJ, Mackay IS (1993) Staging in rhinosinusitus. Rhinology 31(4):183\u2013184","journal-title":"Rhinology"},{"issue":"1","key":"543_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4193\/Rhino10.097","volume":"49","author":"D Timperley","year":"2011","unstructured":"Timperley D, Srubisky A, Stow N, Marcells GN, Harvey RJ (2011) Minimal clinically important differences in nasal peak inspiratory flow. Rhinology 49(1):37\u201340","journal-title":"Rhinology"},{"issue":"2","key":"543_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/01.mlg.0000198338.05826.18","volume":"116","author":"JP Browne","year":"2006","unstructured":"Browne JP, Hopkins C, Slack R, Topham J, Reeves B, Lund V et al (2006) Health-related quality of life after polypectomy with and without additional surgery. Laryngoscope 116(2):297\u2013302","journal-title":"Laryngoscope"},{"issue":"1","key":"543_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1046\/j.1365-2273.2003.00663.x","volume":"28","author":"JR Buckland","year":"2003","unstructured":"Buckland JR, Thomas S, Harries PG (2003) Can the sino-nasal outcome test (SNOT-22) be used as a reliable outcome measure for successful septal surgery? Clin Otolaryngol Allied Sci 28(1):43\u201347","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"543_CR36","unstructured":"Maruish M, Kosinkski M, Bjorner JB, Gandek B, Turner-Bowker DM, Ware JE (2011) User\u2019s manual for the SF36v2 health survey. Quality Metric Incorporated. 3rd ed"},{"issue":"5","key":"543_CR37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM (1993) The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4(5):353\u2013365","journal-title":"Pharmacoeconomics"},{"key":"543_CR38","doi-asserted-by":"crossref","unstructured":"Cohen J (2013) Statistical power analysis for the behavioral sciences, Taylor & Francis","DOI":"10.4324\/9780203771587"},{"issue":"2","key":"543_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3102\/10769986006002107","volume":"6","author":"LV Hedges","year":"1981","unstructured":"Hedges LV (1981) Distribution theory for Glass\u2019s estimator of effect size and related estimators. J Educ Stat 6(2):107\u2013128","journal-title":"J Educ Stat"},{"issue":"2","key":"543_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki D, Hays RD, Cella D, Sloan J (2008) Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol 61(2):102\u2013109","journal-title":"J Clin Epidemiol"},{"key":"543_CR41","unstructured":"Fda U (2018) Patient-focused drug development guidance public workshop: methods to Identify What is Important to Patients & Select, Develop or Modify Fit-for-Purpose Clinical Outcomes Assessments [Workshop]. https:\/\/www.fda.gov\/media\/116277\/download"},{"key":"543_CR42","unstructured":"FDA (2019) Patient-Focused Drug Development Guidance Public Workshop: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision-Making. https:\/\/www.fda.gov\/media\/132505\/download. Accessed Feb 2021"},{"issue":"10","key":"543_CR43","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1007\/s11136-021-02925-y","volume":"30","author":"CB Terwee","year":"2021","unstructured":"Terwee CB, Peipert JD, Chapman R, Lai JS, Terluin B, Cella D et al (2021) Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Qual Life Res: Int J Qual Life Aspect Treat Care Rehabilit 30(10):2729\u20132754","journal-title":"Qual Life Res: Int J Qual Life Aspect Treat Care Rehabilit"},{"issue":"10","key":"543_CR44","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1007\/s11136-021-02897-z","volume":"30","author":"RD Hays","year":"2021","unstructured":"Hays RD, Peipert JD (2021) Between-group minimally important change versus individual treatment responders. Qual Life Res: Int J Qual Life Asp Treat Care Rehabilit 30(10):2765\u20132772","journal-title":"Qual Life Res: Int J Qual Life Asp Treat Care Rehabilit"},{"key":"543_CR45","volume-title":"Mplus user\u2019s guide","author":"LK Muth\u00e9n","year":"2017","unstructured":"Muth\u00e9n LK, Muth\u00e9n BO (2017) Mplus user\u2019s guide, 8th edn. Muth\u00e9n & Muth\u00e9n, Los Angeles","edition":"8"},{"issue":"7","key":"543_CR46","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/lary.25223","volume":"125","author":"DT Nguyen","year":"2015","unstructured":"Nguyen DT, Bey A, Arous F, Nguyen-Thi PL, Felix-Ravelo M, Jankowski R (2015) Can surgeons predict the olfactory outcomes after endoscopic surgery for nasal polyposis? Laryngoscope 125(7):1535\u20131540","journal-title":"Laryngoscope"},{"issue":"11","key":"543_CR47","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1111\/all.14408","volume":"75","author":"SF Seys","year":"2020","unstructured":"Seys SF, De Bont S, Fokkens WJ, Bachert C, Alobid I, Bernal-Sprekelsen M et al (2020) Real-life assessment of chronic rhinosinusitis patients using mobile technology: the mySinusitisCoach project by EUFOREA. Allergy 75(11):2867\u20132878","journal-title":"Allergy"},{"issue":"3","key":"543_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","volume":"88","author":"JT Farrar","year":"2000","unstructured":"Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL (2000) Defining the clinically important difference in pain outcome measures. Pain 88(3):287\u2013294","journal-title":"Pain"},{"issue":"2","key":"543_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94(2):149\u2013158","journal-title":"Pain"},{"key":"543_CR50","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jclinepi.2009.10.004","volume":"63","author":"J Browne","year":"2010","unstructured":"Browne J, van der Meulen J, Lewsey J, Lamping D, Black N (2010) Mathematical coupling may account for the association between baseline severity and minimally important difference values. J Clin Epidemiol 63:865\u2013874","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"543_CR51","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00405-019-05320-z","volume":"276","author":"D Dejaco","year":"2019","unstructured":"Dejaco D, Riedl D, Huber A, Moschen R, Giotakis AI, Bektic-Tadic L et al (2019) The SNOT-22 factorial structure in European patients with chronic rhinosinusitis: new clinical insights. Eur Arch Otorhinolaryngol 276(5):1355\u20131365","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"2","key":"543_CR52","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/alr.21866","volume":"7","author":"AK Lidder","year":"2017","unstructured":"Lidder AK, Detwiller KY, Price CP, Kern RC, Conley DB, Shintani-Smith S et al (2017) Evaluating metrics of responsiveness using patient-reported outcome measures in chronic rhinosinusitis. Int Forum Allergy Rhinol 7(2):128\u2013134","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"543_CR53","doi-asserted-by":"publisher","first-page":"AB125","DOI":"10.1016\/j.jaci.2020.12.458","volume":"147","author":"S Lee","year":"2021","unstructured":"Lee S, Tabberer M, Trigg A, Han J, Fokkens W, Naclerio R et al (2021) Mepolizumab improves health related quality of life for patients with chronic rhinosinusitis with nasal polyps: data from the SYNAPSE study. J Allergy Clin Immunol 147(2):AB125","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"543_CR54","doi-asserted-by":"publisher","first-page":"e61191","DOI":"10.1371\/journal.pone.0061191","volume":"8","author":"G Tucker","year":"2013","unstructured":"Tucker G, Adams R, Wilson D (2013) Observed agreement problems between sub-scales and summary components of the SF-36 version 2: an alternative scoring method can correct the problem. PLoS ONE 8(4):e61191","journal-title":"PLoS ONE"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-023-00543-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-023-00543-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-023-00543-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T04:29:29Z","timestamp":1710908969000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-023-00543-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["543"],"URL":"https:\/\/doi.org\/10.1186\/s41687-023-00543-5","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"assertion":[{"value":"4 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent prior to participation in the SYNAPSE study. The study was approved by the local institutional review board or ethics committee at each study center. The approving ethics committees were as follows: <i>Argentina<\/i>: Comite de Etica Dr. Claude Bernard, San Lorenzo 2555, Rosario, Santa Fe, S2000KPG; Comite de etica en Investigacion CEMER, Esmeralda 1550, Florida, Buenos Aires, B1602DQD; Comit\u00e9 Independiente de \u00e9tica para ensayos en Farmacolog\u00eda Clinica del centro Medico Dra. De Salvo, Avenida Cabildo 1536 5\u00b0 B, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1426ABP; Comit\u00e9 de \u00c9tica en Investigaci\u00f3n. INAER, Arenales 3146 1\u00b0A, Ciudad Autonoma de Buenos Aires, Buenos Aires, C1425BEN; Framingham Centro M\u00e9dico, Calle 9 Numero 431, La Plata, Buenos Aires, B1902COS; Comite de Etica en Farmacologia Clinica de la Fundacion CIDEA, Paraguay 2041, Ciudad Autonoma de Buenos Aires, CP1121ABE; Investigaciones en Alergia y Enfermedades Respiratorias, Arenales 3146, Buenos Aires, C1425BEN; Comite de Etica en Investigacion, Instituto Ave Pulmo, Carlos M. Alvear 3345, Mar del Plata, Buenos Aires, B7602DCK; <i>Australia<\/i>: Saint Vincent\u2019s Hospital, Research Office, Level 6, DeLacy Building, Darlinghurst, New South Wales, 2010; Bellberry Limited, 123 Glen Osmond Road, Eastwood, South Australia, 5063; <i>Canada<\/i>: Comit\u00e9 d'\u00e9thique de la recherche du CHU de Qu\u00e9bec, A0-124, Comit\u00e9 d'\u00e9thique de la recherche du CHU de Qu\u00e9bec, Quebec, Qu\u00e9bec, G1L 3L5; Advarra, Suite 300, 372 Hollandview Trail, Aurora, Ontario, L4G 0A5; Comite d\u2019ethique de la Recherche du CHUM, Tour Viger, 3e \u00e9tage, 900, rue St-Denis, Montr\u00e9al, Qu\u00e9bec, H2X 0A9; UBC CREB Office, 210, 828 West 10th Avenue, Vancouver, British Columbia, V5Z 1L8; Hamilton Integrated Research Ethics Board, Suite 102, 293 Wellington Street North, Hamilton, Ontario, L8L 8E7; Western University, Office of Research Ethics, Support Services Building Room 5150, 1151 Richmond Street, London, Ontario, N6G 1G9; University of Saskatchewan, Thorvaldson Building, Room 223, Research Services and Ethics Office, University of Saskatchewan, Saskatoon, Saskatchewan, S7N 5C9; <i>Germany<\/i>: Ethik-Kommission der Landesaerztekammer Hessen, Im Vogelsgesang 3, Frankfurt, Hessen, 60488; <i>Republic of Korea<\/i>: Severance Hospital Clinic Trial Centre, Yonsei University Health System, 50-1 Yonsei-Ro Seodaemun-Gu, Seoul, 03722; Samsung Medical Centre, 81 Irwon-Ro Gangnam-gu, Seoul, 06351; Gachon University of Gil Medical Centre, 21, Namdong-daero 774 bean-gil, Namdong-gu, 21565; The Catholic University of Korea Seoul Saint Mary\u2019s Hospital, 222 Banpo-Daero, Seocho-gu, Seoul, 06591; Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul, 08308; Seoul National University Bundang Hospital, 82 Gumi-ro 173 beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620; <i>Netherlands<\/i>: Medisch Ethische Commissie, Meibergdreef 9, Amsterdam, 1105 AZ; <i>Romania<\/i>: Comisia Nationala de Bioetica a medicamentelor si a Dispozitivelor Medicale, Pavilion K, Spitalul Clinic Colentina, Sos. Stefan cel Mare near 19-21, Bucuresti, 020125; <i>Russia<\/i>: Independent Ethics Committee PharmNadzor, office 618, 4, Komendantskiy Prospect, Lit.A, Saint-Petersburg, 197227; GOU VPO Saint.Petersburg State Medical University \"I.P.Pavlova\", 6\\8,Lva Tolstogo, Saint Petersburg, 197022; Federal medical biophysical center n.a. A.I. Burnazyan of FMBA of Russia, 23, Marshala Novikova Strasse., Moscow, 123098; Hospital of Russian Academy of Science, Troitsk city, Oktyabrskiy prospect, 3, Moscow, 142190; Inter-Institutional ETHICS COMMITTEE, per. Gagarinskiy, d. 37, Strasse. 2, Moscow, 119002; Scientific Clinical Center of Otorhinolaryngology, 30\/2, Volokolamskoe shosse, Moscow, 123182; ENT Research Institute, 9, Bronnitskaya Street, Saint-Petersburg, 190013; I.M. Sechenov First Moscow State Medical University, Local Ethics Committee of Federal State Autonomous Educational Institution of Higher Education, 8, ul. Trubetskaya, Moscow, 119991; I.M.Sechenov First Moscow State Medical University of Ministry of health and social development, Local Ethics Committee of State budget educational institution of higher professional education, 8 Trubetskaya street, Moscow; Municipal Health Care Institution Clinical Hospital for Emergency Medical Care, 11 Zagorodny Sad., Yaroslavl, 150003; <i>Sweden<\/i>: Regionala Etikpr\u00f6vningsn\u00e4mnden i G\u00f6teborg, Guldhedsgatan 5A, G\u00f6teborg, SE-413 20; <i>United Kingdom<\/i>: NRES Committee East Midlands-Leicester, The Old Chapel, Royal Standard Place, Nottingham, NG1 6FS; <i>United States of America<\/i>: University of Utah Institutional Review Board, Research Administration Building, 75 South 2000 East, Salt Lake City, Utah, 84112; Advarra Institutional Review Board, Suite 110, 6940 Columbia Gateway Drive, Columbia, Maryland, 21046; Penn State college of Medicine Institutional Review Board\/Human Subjects Protection Office, Penn State Hershey Medical Center, Mailcode A115, 90 Hope Drive, Hershey, Pennsylvania, 17033, 855; University of California, San Diego (UCSD) Human Research Protection Program Office (HRPP), 9452 Medical Center drive, La Jolla, California, 92093; University of Texas Southwestern Medical Center Institutional Review Board, Room BL9.100, 5323 Harry Hines Boulevard, Dallas, Texas, 75390-8843; Office of Research Integrity, Institutional Review for Human Research, 19 Hagwood Avenue, Suite 601, Charleston, South California, 29425.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"WF has received clinical trial funding from Sanofi, Mylan, ALK, Allergy Therapeutics, Novartis, and Chordate, personal fees from GSK, Sanofi and Novartis, has participated on an advisory board for Lyra, and is Secretary General of the European Rhinologic Society. AT was employed by Adelphi Values during the conduct of the study and is currently an employee of Bayer Plc. SEL has participated in advisory boards and received clinical trial funding from Sanofi Genzyme, Regeneron, Genentech, AstraZeneca, and GSK. RHC, PH, BM, ARS and SY are all employees of GSK and own stocks\/shares in GSK. MT was an employee of GSK at the time of the study and owns stocks\/shares in GSK. ZD has acted as Research Director at QPS-NL, an institution which has received research support from HAL Allergy, Foresee Pharmaceuticals, Patara Pharma (now Respivant) and Novartis. ZD has also received honoraria or speaker fees serving on advisory boards or as a consultant for ALK, Antabio, AstraZeneca, Boehringer Ingelheim, Merck Sharp & Dohme, QPS-NL and Sanofi-Genzyme-Regeneron. CH has received advisory board fees from Sanofi, AstraZeneca, Olympus, Dianosic, and GSK, and has received honoraria for lectures from GSK, Sanofi, Intersect, and Mylan. VL reports advisory board and lecture fees from GSK, Novartis, and Sanofi.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}